Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Cycle

• Publication date

  2013-01-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.23409PMID 23324394PMCID PMC3594260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

  2012influential reference
• Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe

  2010cited by this paper
• Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer

  2010cited by this paper
• siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model

  2010cited by this paper
• Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc

  2009cited by this paper
• SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.

  2009cited by this paper
• Cell cycle kinases as therapeutic targets for cancer

  2009cited by this paper
• Artemis Regulates Cell Cycle Recovery from the S Phase Checkpoint by Promoting Degradation of Cyclin E*

  2009cited by this paper
• Sequencing newly replicated DNA reveals widespread plasticity in human replication timing

  2009cited by this paper
• CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.

  2008cited by this paper
• The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.

  2008cited by this paper
• Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase

  2008cited by this paper
• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo.

  2008cited by this paper
• Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation

  2008cited by this paper
• The FBXW7 β-form is suppressed in human glioma cells

  2007cited by this paper
• Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.

  2007cited by this paper
• The FBXW7 beta-form is suppressed in human glioma cells.

  2007cited by this paper
• p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability

  2007cited by this paper
• MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer

  2007cited by this paper
• Cyclin E overexpression impairs progression through mitosis by inhibiting APCCdh1

  2007cited by this paper
• Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.

  2006cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Cyclin E Expression and Prognosis in Breast Cancer Patients: A Meta-Analysis of Published Studies

  2006cited by this paper
• Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.

  2006cited by this paper
• Ras activity regulates cyclin E degradation by the Fbw7 pathway.

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Cyclin E in normal and neoplastic cell cycles

  2005cited by this paper
• Mutation of hCDC4 Leads to Cell Cycle Deregulation of Cyclin E in Cancer

  2004cited by this paper
• High Physiological Levels of LMP1 Result in Phosphorylation of eIF2α in Epstein-Barr Virus-Infected Cells

  2004cited by this paper
• Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes

  2004cited by this paper
• Deregulation of cyclin E in human cells interferes with prereplication complex assembly

  2004cited by this paper
• Cyclin E ablation in the mouse.

  2003cited by this paper
• Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.

  2003cited by this paper
• Negative regulation of transcription by the type II arginine methyltransferase PRMT5

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2*

  2001cited by this paper
• Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer.

  2001cited by this paper
• Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase

  2001cited by this paper
• Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication

  2000cited by this paper
• Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers

  1999cited by this paper
• Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins

  1998cited by this paper
• Bivariate Analysis of DNA Content and Expression of Cyclin Proteins

  1998cited by this paper
• c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry

  1998cited by this paper
• Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle

  1998cited by this paper
• Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2*

  1997cited by this paper
• Principles and Applications

  1997cited by this paper
• Flow cytometry: principles and applications. I.

  1984cited by this paper

• PTPN18 functions as a tumor suppressor in breast cancer by negatively regulating cyclin E

  2025cites this paper
• CCNE1 Gene Amplification Might Be Associated with Lymph Node Metastasis of Gastric Cancer

  2025cites this paper
• Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer

  2023cites this paper
• The role of cell cycle in reprogramming toward induced pluripotent stem cells (iPSCs)

  2022cites this paper
• Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition

  2021cites this paper
• Cyclins E1 and E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets.

  2020cites this paper
• Eimeria bovis infections induce G1 cell cycle arrest and a senescence-like phenotype in endothelial host cells

  2020cites this paper
• Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer

  2020cites this paper
• Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between CDK2 and PARP inhibitors

  2020cites this paper
• Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

  2020cites this paper
• Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  2019cites this paper
• PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in breast cancer.

  2019cites this paper
• Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis

  2018cites this paper
• Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny

  2018influential citation
• Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.

  2016cites this paper
• Combinatorial PX‐866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF‐7 Breast Cancer Cells

  2016cites this paper
• Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.

  2016cites this paper
• AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.

  2016cites this paper
• p53‐dependent up‐regulation of CDKN1A and down‐regulation of CCNE2 in response to beryllium

  2016cites this paper
• MicroRNA-27b Enhances the Hepatic Regenerative Properties of Adipose-Derived Mesenchymal Stem Cells

  2016cites this paper
• A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness

  2015cites this paper
• Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

  2015cites this paper
• Aberrant regulation of FBW7 in cancer

  2014cites this paper
• Aberrant regulation of FBW 7 in cancer

  2014cites this paper
• The control of the cell cycle with particular emphasis on the G1/S transition

  2014cites this paper
• Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle

  2014cites this paper
• Similar, not the same

  2013cites this paper
• ATM targets hnRNPK to control p53

  2013cites this paper